- FTC Approves Final Order Imposing Conditions on Boston Scientific Corp.’s Acquisition of BTG plc ( )
- FTC Approves Final Order Imposing Conditions on UnitedHealth Group’s Proposed Acquisition of DaVita Medical Group ( )
- FTC Requires Divestitures and Imposes Conditions on Boston Scientific Corp.’s Acquisition of BTG plc ( )
- After Healthcare System Sanford Health Abandons Acquisition of North Dakota Healthcare Provider Mid Dakota Clinic, FTC Dismisses Case from Administrative Trial Process ( )
- FTC Imposes Conditions on UnitedHealth Group’s Proposed Acquisition of DaVita Medical Group ( )
- FTC to Hold Workshop Tomorrow Regarding the Impact of Certificates of Public Advantage ( )
- FTC Announces Agenda for June 18 Workshop, A Health Check on COPAs ( )
- FTC Submits Comment on Proposed Information Blocking Rule to the Department of Health & Human Services Office of the National Coordinator for Health Information Technology (ONC) ( )
- FTC Submits Comment on FDA Guidance Regarding Nonproprietary Naming of Biological Products ( )
- Administrative Law Judge Upholds FTC’s Complaint Challenging Consummated Merger of Companies that Make Microprocessor Prosthetic Knees ( )
- FTC Charges Surescripts with Illegal Monopolization of E-Prescription Markets ( )
- FTC to Hold Workshop on Certificates of Public Advantage in Healthcare Markets ( )
- FTC Approves Final Order Imposing Conditions on Merger of Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. ( )
- FTC Concludes that Impax Entered into Illegal Pay-for-Delay Agreement ( )
- FTC Staff Testifies in Favor of Repealing Alaska Laws that Limit Competition in the Health Care Sector ( )
- FTC Chairman Releases 2018 Annual Highlights ( )
- FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger ( )
- FTC Approves Teva Petition to Reopen and Modify Decision and Order in Case Involving Watson Pharmaceuticals Inc.’s Acquisition of Actavis Inc. ( )
- FTC Submits Comment on FDA Guidance Aimed at Deterring Abuse of Citizen Petition Process ( )
- Statement of Federal Trade Commission Concerning Its Vote to Close the Investigation of a Proposed Transaction Combining Massachusetts Healthcare Providers ( )
- Teva Petitions FTC to Reopen and Modify Decision and Order in Case Involving Watson Pharmaceuticals Inc.’s Acquisition of Actavis Inc. ( )
- FTC Approves Final Order Requiring Grifols S.A. to Divest Assets as Condition of Acquiring Biotest US Corporation ( )
- FTC Requires Grifols S.A. to Divest Assets as Condition of Acquiring Biotest US Corporation ( )
- Therapist Staffing Company and Two Owners Settle Charges that They Colluded on Rates Paid to Physical Therapists in Dallas/Fort Worth Area ( )
- FTC Submits Statement to HHS on Its Blueprint to Lower Drug Prices ( )
- Statement of FTC Chairman Joe Simons Regarding Federal Court Ruling in FTC v. AbbVie ( )
- FTC Amicus Brief Urges Federal District Court Not to Categorically Exempt Hatch Waxman Suits from Antitrust Scrutiny as Potential Sham Litigations ( )
- FTC Approves Final Order Imposing Conditions on Merger of Air Medical Group Holdings, Inc. and AMR Holdco, Inc. ( )
- FTC Acting Chairman Releases 2017 Annual Highlights ( )
- FTC Staff Comment Supports Proposal to Enhance Access to Dental Care in New York ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.